Reviewing Better Therapeutics (NASDAQ:BTTX) & Vsee Health (NASDAQ:VSEE)

Better Therapeutics (NASDAQ:BTTX) and Vsee Health (NASDAQ:VSEE) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, analyst recommendations, earnings, risk and institutional ownership.

Institutional and Insider Ownership

34.0% of Better Therapeutics shares are held by institutional investors. Comparatively, 1.0% of Vsee Health shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by insiders. Comparatively, 6.6% of Vsee Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Better Therapeutics and Vsee Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Better Therapeutics	N/A	N/A	N/A
Vsee Health	N/A	-182.59%	-58.26%

Analyst Ratings

This is a summary of recent ratings for Better Therapeutics and Vsee Health, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Better Therapeutics	0	0	0	0	0.00
Vsee Health	0	0	0	1	4.00

Vsee Health has a consensus price target of $5.00, suggesting a potential upside of 296.83%. Given Vsee Health’s stronger consensus rating and higher probable upside, analysts clearly believe Vsee Health is more favorable than Better Therapeutics.

Valuation and Earnings

This table compares Better Therapeutics and Vsee Health”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Better Therapeutics	N/A	N/A	-$39.76 million	N/A	N/A
Vsee Health	$6.38 million	0.71	-$4.41 million	N/A	N/A

Vsee Health has higher revenue and earnings than Better Therapeutics.

Summary

Vsee Health beats Better Therapeutics on 5 of the 9 factors compared between the two stocks.

About Better Therapeutics

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

About Vsee Health

VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.